| The Role of the Liver in Sepsis LS Yan J1, Li S Int Rev Immunol 33 (6), 498-510, 2014 | 512* | 2014 |
| DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial–mesenchymal transition in human breast cancer Q Lv, W Wang, J Xue, F Hua, R Mu, H Lin, J Yan, X Lv, X Chen, ZW Hu Cancer research 72 (13), 3238-3250, 2012 | 181 | 2012 |
| TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury HZ Yang, JP Wang, SU Mi, HZ Liu, B Cui, HM Yan, J Yan, Z Li, H Liu, ... The American journal of pathology 180 (1), 275-292, 2012 | 168 | 2012 |
| TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations F Hua, K Li, JJ Yu, XX Lv, J Yan, XW Zhang, W Sun, H Lin, S Shang, ... Nature communications 6 (1), 7951, 2015 | 142 | 2015 |
| Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice Y Ma, X Zhang, H Bao, S Mi, W Cai, H Yan, Q Wang, Z Wang, J Yan, ... PloS one 7 (7), e40763, 2012 | 115 | 2012 |
| IL‐30 (IL27p28) attenuates liver fibrosis through inducing NKG2D‐rae1 interaction between NKT and activated hepatic stellate cells in mice A Mitra, A Satelli, J Yan, X Xueqing, M Gagea, CA Hunter, L Mishra, S Li Hepatology 60 (6), 2027-2039, 2014 | 111 | 2014 |
| Loss of immunity‐supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll‐like receptor 2‐deficient mice H Lin, J Yan, Z Wang, F Hua, J Yu, W Sun, K Li, H Liu, H Yang, Q Lv, ... Hepatology 57 (1), 171-182, 2013 | 110 | 2013 |
| FGL2 as a multimodality regulator of tumor-mediated immune suppression and therapeutic target in gliomas J Yan, LY Kong, J Hu, K Gabrusiewicz, D Dibra, X Xia, AB Heimberger, ... Journal of the National Cancer Institute 107 (8), djv137, 2015 | 109 | 2015 |
| Blocking TLR2 activity attenuates pulmonary metastases of tumor HZ Yang, B Cui, HZ Liu, S Mi, J Yan, HM Yan, F Hua, H Lin, WF Cai, ... PloS one 4 (8), e6520, 2009 | 108 | 2009 |
| FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation J Yan, Q Zhao, K Gabrusiewicz, LY Kong, X Xia, J Wang, M Ott, J Xu, ... Nature communications 10 (1), 448, 2019 | 85 | 2019 |
| Intracellular or extracellular heat shock protein 70 differentially regulates cardiac remodelling in pressure overload mice WF Cai, XW Zhang, HM Yan, YG Ma, XX Wang, J Yan, BM Xin, XX Lv, ... Cardiovascular research 88 (1), 140-149, 2010 | 76 | 2010 |
| IL6‐mediated inflammatory loop reprograms normal to epithelial‐mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta … A Mitra, J Yan, X Xia, S Zhou, J Chen, L Mishra, S Li Hepatology 65 (4), 1222-1236, 2017 | 70 | 2017 |
| Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme J Hu, Q Zhao, LY Kong, J Wang, J Yan, X Xia, Z Jia, AB Heimberger, S Li Science Advances 7 (5), eabc2511, 2021 | 68 | 2021 |
| The duality of Fgl2-secreted immune checkpoint regulator versus membrane-associated procoagulant: therapeutic potential and implications J Hu, J Yan, G Rao, K Latha, WW Overwijk, AB Heimberger, S Li International reviews of immunology 35 (4), 325-339, 2016 | 68 | 2016 |
| Toll‐like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice Z Wang, J Yan, H Lin, F Hua, X Wang, H Liu, X Lv, J Yu, S Mi, J Wang, ... Hepatology 57 (5), 1869-1881, 2013 | 65 | 2013 |
| Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells H Noh, J Yan, S Hong, LY Kong, K Gabrusiewicz, X Xia, AB Heimberger, ... Oncotarget 7 (44), 72021, 2016 | 54 | 2016 |
| Bacillus Calmette-Guerin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment YY Liu, WF Cai, HZ Yang, B Cui, ZR Chen, HZ Liu, J Yan, W Jin, HM Yan, ... The Journal of Immunology 180 (11), 7349-7357, 2008 | 53 | 2008 |
| Synthesis, biological evaluation, and molecular modeling of glycyrrhizin derivatives as potent high-mobility group box-1 inhibitors with anti-heart-failure activity in vivo D Du, J Yan, J Ren, H Lv, Y Li, S Xu, Y Wang, S Ma, J Qu, W Tang, Z Hu, ... Journal of Medicinal Chemistry 56 (1), 97-108, 2013 | 40 | 2013 |
| Timing is critical for an effective anti-metastatic immunotherapy: the decisive role of IFNγ/STAT1-mediated activation of autophagy J Yan, ZY Wang, HZ Yang, HZ Liu, S Mi, XX Lv, XM Fu, HM Yan, ... PloS one 6 (9), e24705, 2011 | 38 | 2011 |
| The role of fibrinogen-like protein 2 on immunosuppression and malignant progression in glioma K Latha, J Yan, Y Yang, LV Gressot, LY Kong, G Manyam, R Ezhilarasan, ... JNCI: Journal of the National Cancer Institute 111 (3), 292-300, 2019 | 37 | 2019 |
